JP2024026214A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024026214A5 JP2024026214A5 JP2023201609A JP2023201609A JP2024026214A5 JP 2024026214 A5 JP2024026214 A5 JP 2024026214A5 JP 2023201609 A JP2023201609 A JP 2023201609A JP 2023201609 A JP2023201609 A JP 2023201609A JP 2024026214 A5 JP2024026214 A5 JP 2024026214A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- composition
- subject
- administered
- rhasm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024217551A JP2025038063A (ja) | 2009-08-28 | 2024-12-12 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23811309P | 2009-08-28 | 2009-08-28 | |
| US61/238,113 | 2009-08-28 | ||
| JP2020005901A JP6952810B2 (ja) | 2009-08-28 | 2020-01-17 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2021157902A JP7167281B2 (ja) | 2009-08-28 | 2021-09-28 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2022171242A JP7395693B2 (ja) | 2009-08-28 | 2022-10-26 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022171242A Division JP7395693B2 (ja) | 2009-08-28 | 2022-10-26 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024217551A Division JP2025038063A (ja) | 2009-08-28 | 2024-12-12 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024026214A JP2024026214A (ja) | 2024-02-28 |
| JP2024026214A5 true JP2024026214A5 (enExample) | 2024-03-19 |
| JP7605949B2 JP7605949B2 (ja) | 2024-12-24 |
Family
ID=43625265
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012527054A Active JP5955219B2 (ja) | 2009-08-28 | 2010-08-28 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2016041242A Active JP6251307B2 (ja) | 2009-08-28 | 2016-03-03 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2017226255A Pending JP2018076322A (ja) | 2009-08-28 | 2017-11-24 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2020005901A Active JP6952810B2 (ja) | 2009-08-28 | 2020-01-17 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2021157902A Active JP7167281B2 (ja) | 2009-08-28 | 2021-09-28 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2022171242A Active JP7395693B2 (ja) | 2009-08-28 | 2022-10-26 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2023201609A Active JP7605949B2 (ja) | 2009-08-28 | 2023-11-29 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2024217551A Pending JP2025038063A (ja) | 2009-08-28 | 2024-12-12 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Family Applications Before (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012527054A Active JP5955219B2 (ja) | 2009-08-28 | 2010-08-28 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2016041242A Active JP6251307B2 (ja) | 2009-08-28 | 2016-03-03 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2017226255A Pending JP2018076322A (ja) | 2009-08-28 | 2017-11-24 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2020005901A Active JP6952810B2 (ja) | 2009-08-28 | 2020-01-17 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2021157902A Active JP7167281B2 (ja) | 2009-08-28 | 2021-09-28 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
| JP2022171242A Active JP7395693B2 (ja) | 2009-08-28 | 2022-10-26 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024217551A Pending JP2025038063A (ja) | 2009-08-28 | 2024-12-12 | 酸性スフィンゴミエリナーゼ欠乏症に対する用量漸増酵素補充療法 |
Country Status (30)
| Country | Link |
|---|---|
| US (9) | US8349319B2 (enExample) |
| EP (4) | EP2470199B1 (enExample) |
| JP (8) | JP5955219B2 (enExample) |
| KR (6) | KR102094253B1 (enExample) |
| CN (3) | CN105999238A (enExample) |
| AU (6) | AU2010286550B2 (enExample) |
| BR (1) | BR112012004377A2 (enExample) |
| CA (1) | CA2773133A1 (enExample) |
| CL (1) | CL2012000495A1 (enExample) |
| CY (1) | CY1122128T1 (enExample) |
| DK (3) | DK3482767T3 (enExample) |
| ES (3) | ES3052684T3 (enExample) |
| FI (2) | FI3998078T3 (enExample) |
| FR (1) | FR22C1062I2 (enExample) |
| HR (3) | HRP20251310T1 (enExample) |
| HU (3) | HUE057440T2 (enExample) |
| IL (4) | IL314807A (enExample) |
| LT (4) | LT3998078T (enExample) |
| LU (1) | LUC00288I2 (enExample) |
| MX (2) | MX356873B (enExample) |
| NL (1) | NL301211I2 (enExample) |
| NO (1) | NO2022054I1 (enExample) |
| PL (3) | PL2470199T3 (enExample) |
| PT (3) | PT3482767T (enExample) |
| RU (2) | RU2731616C2 (enExample) |
| SI (3) | SI2470199T1 (enExample) |
| SM (1) | SMT202500432T1 (enExample) |
| TR (1) | TR201911293T4 (enExample) |
| WO (1) | WO2011025996A2 (enExample) |
| ZA (2) | ZA201201435B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006007560A2 (en) | 2004-07-01 | 2006-01-19 | University Of Pennsylvania | Targeted protein replacement for the treatment of lysosomal storage disorders |
| US20080228056A1 (en) | 2007-03-13 | 2008-09-18 | Michael Blomquist | Basal rate testing using frequent blood glucose input |
| US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
| US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
| PL2158322T3 (pl) | 2007-06-06 | 2017-10-31 | Genzyme Corp | Terapia genowa dla lizosomalnych chorób spichrzeniowych |
| CA2773133A1 (en) * | 2009-08-28 | 2011-03-03 | Edward H. Schuchman | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| US8882701B2 (en) | 2009-12-04 | 2014-11-11 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
| EP2571997A2 (en) | 2010-05-21 | 2013-03-27 | Ohmx Corporation | Enzymatic activity of psa as diagnostic marker for prostate cancer |
| LT2685986T (lt) | 2011-03-18 | 2020-03-10 | Genzyme Corporation | Gliukozilceramido sintazės slopiklis |
| US10350277B2 (en) | 2011-09-07 | 2019-07-16 | Icahn School Of Medicine At Mount Sinai | Ceramidase and cell differentiation |
| JP6243846B2 (ja) | 2011-11-15 | 2017-12-06 | セントジーン アーゲー | ニーマン・ピック病の診断のための方法 |
| ES2786128T3 (es) | 2012-06-01 | 2020-10-08 | Icahn School Med Mount Sinai | Niveles de ceramida en el tratamiento y prevención de infecciones |
| MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
| JP6832158B2 (ja) | 2013-03-14 | 2021-02-24 | アイカーン スクール オブ メディシン アット マウント サイナイ | 治療用酸性セラミダーゼ組成物ならびにそれを作製および使用する方法 |
| JO3713B1 (ar) | 2013-03-15 | 2021-01-31 | Genzyme Corp | أشكال ملح (s)-كوينوكليدين-3-يل(2-(2-(4-فلوروفينيل)ثيازول-4-يل)بروبان-2-يل)كارباميت |
| TR201906195T4 (tr) * | 2013-05-14 | 2019-05-21 | Centogene Ag | Niemann pıck hastalığının teşhisi için metot. |
| MX370570B (es) | 2013-06-07 | 2019-12-17 | Genzyme Corp | Marcador para trastornos de la esfingomielinasa acida y sus usos. |
| JP6984854B2 (ja) * | 2015-10-08 | 2021-12-22 | 国立大学法人千葉大学 | ニーマン・ピック病ｃ型を予防または治療するための医薬組成物 |
| US10569016B2 (en) | 2015-12-29 | 2020-02-25 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
| PL3672622T3 (pl) * | 2017-08-24 | 2024-04-02 | Genzyme Corporation | Rekombinowana ludzka kwaśna sfingomielinaza do zastosowania w leczeniu nieprawidłowych stanów kości u pacjentów z niedoborem kwaśnej sfingomielinazy |
| FR3070383B1 (fr) | 2017-08-31 | 2021-08-20 | Solable | Appareil de traitement d'eau |
| BR112020005271A2 (pt) | 2017-10-02 | 2020-09-15 | Denali Therapeutics Inc. | proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica |
| PY1939780A (es) * | 2018-05-25 | 2019-12-04 | Genzyme Corp | Composiciones farmacéuticas para el tratamiento de la deficiencia de esfingomielinasa ácida |
| PT3920912T (pt) | 2019-02-04 | 2025-09-09 | Genzyme Corp | Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs) |
| IL295255A (en) | 2020-02-03 | 2022-10-01 | Genzyme Corp | Methods for treating neurological symptoms associated with lysosomal storage diseases |
| IL300090A (en) | 2020-07-24 | 2023-03-01 | Genzyme Corp | Pharmaceutical preparations containing VENGLUSTAT |
| CN117396517A (zh) * | 2021-05-27 | 2024-01-12 | 梨树爱博思股份有限公司 | 与酸性鞘磷脂酶蛋白特异性结合的抗体 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4082781A (en) | 1976-06-04 | 1978-04-04 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis of 2-alkanoylamino-4-nitrophenyl phosphorylcholine-hydroxide |
| US4039388A (en) | 1976-06-04 | 1977-08-02 | The United States Of America As Represented By The Government | Diagnostic test for Niemann-Pick disease |
| IL74761A0 (en) | 1984-04-13 | 1985-06-30 | Hughes Howard Med Inst | Human phenylalanine hydroxylase cdna clones,their production and their use in diagnosing classical phenylketonuria |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4863195A (en) * | 1987-10-02 | 1989-09-05 | Capozzola Carl A | Identification tag |
| US5047335A (en) | 1988-12-21 | 1991-09-10 | The Regents Of The University Of Calif. | Process for controlling intracellular glycosylation of proteins |
| US5549892A (en) | 1988-12-23 | 1996-08-27 | Genzyme Corporation | Enhanced in vivo uptake of glucocerebrosidase |
| US5773278A (en) | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
| US5484719A (en) | 1991-08-26 | 1996-01-16 | Edible Vaccines, Inc. | Vaccines produced and administered through edible plants |
| US5612487A (en) | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
| US6034298A (en) | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5716614A (en) | 1994-08-05 | 1998-02-10 | Molecular/Structural Biotechnologies, Inc. | Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier |
| EP0865499B1 (en) | 1995-09-14 | 2009-03-18 | Virginia Tech Intellectual Properties, Inc. | Production of lysosomal enzymes in plant-based expression systems |
| JP2820106B2 (ja) | 1996-02-29 | 1998-11-05 | 日本電気株式会社 | トラヒックシェーパ装置 |
| US20050032211A1 (en) | 1996-09-26 | 2005-02-10 | Metabogal Ltd. | Cell/tissue culturing device, system and method |
| IL155588A0 (en) | 2003-04-27 | 2003-11-23 | Metabogal Ltd | Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby |
| MXPA01006491A (es) | 1998-12-23 | 2003-06-06 | Thompson Boyce Plant Res | Expresion de antigenos de superficie de hepatitis b inmunogenicos en plantas transgenicas. |
| US6534300B1 (en) | 1999-09-14 | 2003-03-18 | Genzyme Glycobiology Research Institute, Inc. | Methods for producing highly phosphorylated lysosomal hydrolases |
| US6770799B2 (en) | 2000-03-17 | 2004-08-03 | Thompson Boyce Plant Res | Expression of recombinant human acetylcholinesterase in transgenic plants |
| US20020095135A1 (en) * | 2000-06-19 | 2002-07-18 | David Meeker | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| US7138262B1 (en) | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
| AU2001286636A1 (en) | 2000-08-25 | 2002-03-13 | Lysometrix Corporation | Method for assaying the activity of lysosomal enzymes |
| US7001994B2 (en) | 2001-01-18 | 2006-02-21 | Genzyme Corporation | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins |
| US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| EP1436316B1 (en) | 2001-04-30 | 2008-01-23 | ZyStor Therapeutics , Inc. | Subcellular targeting of therapeutic proteins |
| US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| IES20011101A2 (en) * | 2001-12-21 | 2003-06-25 | Japkinstill Services Ltd | A Bi-directional Messaging System |
| US7658916B2 (en) | 2002-04-05 | 2010-02-09 | Genzyme Corporation | Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density |
| US7585518B2 (en) | 2002-11-19 | 2009-09-08 | Kimberly-Clark Worldwide, Inc. | Products and methods for maintaining or increasing ceramide levels in skin |
| US7388079B2 (en) | 2002-11-27 | 2008-06-17 | The Regents Of The University Of California | Delivery of pharmaceutical agents via the human insulin receptor |
| US7951557B2 (en) | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
| BRPI0411291A (pt) * | 2003-06-12 | 2006-08-01 | Genzyme Corp | esfingomielinase acida humana modificada tendo atividade aumentada e métodos para a fabricação da mesma |
| US20050026823A1 (en) * | 2003-06-20 | 2005-02-03 | Biomarin Pharmaceutical Inc. | Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues |
| US7442372B2 (en) | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
| CN1897957A (zh) | 2003-11-25 | 2007-01-17 | 纽约大学西奈山医学院 | 尼曼－皮克病的基于陪伴分子的治疗 |
| KR20070085291A (ko) | 2004-10-13 | 2007-08-27 | 프로탈릭스 리미티드 | 식물 세포 배양에서 항체를 생산하는 시스템 및 방법 |
| US7615224B2 (en) | 2004-12-02 | 2009-11-10 | Women's And Children's Hospital | Multiplex-bead complex for determination of lysosomal storage disorders |
| CA2634042A1 (en) | 2005-12-15 | 2007-07-12 | The Research Foundation Of State University Of New York | Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine |
| AR059089A1 (es) * | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
| CA2641070C (en) | 2006-02-06 | 2017-01-03 | Ramot At Tel-Aviv University Ltd. | Enzyme replacement therapy for treating lysosomal storage diseases |
| CN101404927A (zh) * | 2006-02-09 | 2009-04-08 | 建新公司 | 慢速脑室内递送 |
| US8124103B2 (en) | 2006-02-13 | 2012-02-28 | Fraunhofer Usa, Inc | Influenza antigens, vaccine compositions, and related methods |
| JP5302189B2 (ja) | 2007-04-27 | 2013-10-02 | 長瀬産業株式会社 | スフィンゴミエリナーゼ |
| US20110237538A1 (en) | 2008-08-06 | 2011-09-29 | Summit Corporation Plc | Treatment of lysosomal storage disorders and other proteostatic diseases |
| EP3608330B1 (en) | 2008-12-16 | 2022-11-09 | Genzyme Corporation | Synthetic intermediates for preparing oligosaccharide-protein conjugates |
| CA2773133A1 (en) * | 2009-08-28 | 2011-03-03 | Edward H. Schuchman | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| ES2664844T3 (es) * | 2011-06-20 | 2018-04-23 | Mount Sinai School Of Medicine | Tratamiento dirigido contra TNF para las mucopolisacaridosis y otros trastornos lisosómicos |
| MX370570B (es) * | 2013-06-07 | 2019-12-17 | Genzyme Corp | Marcador para trastornos de la esfingomielinasa acida y sus usos. |
| PL3672622T3 (pl) * | 2017-08-24 | 2024-04-02 | Genzyme Corporation | Rekombinowana ludzka kwaśna sfingomielinaza do zastosowania w leczeniu nieprawidłowych stanów kości u pacjentów z niedoborem kwaśnej sfingomielinazy |
-
2010
- 2010-08-28 CA CA2773133A patent/CA2773133A1/en active Pending
- 2010-08-28 AU AU2010286550A patent/AU2010286550B2/en active Active
- 2010-08-28 HR HRP20251310TT patent/HRP20251310T1/hr unknown
- 2010-08-28 KR KR1020127005293A patent/KR102094253B1/ko active Active
- 2010-08-28 RU RU2015145255A patent/RU2731616C2/ru active
- 2010-08-28 WO PCT/US2010/047057 patent/WO2011025996A2/en not_active Ceased
- 2010-08-28 ES ES21200695T patent/ES3052684T3/es active Active
- 2010-08-28 LT LTEP21200695.1T patent/LT3998078T/lt unknown
- 2010-08-28 EP EP10812683.0A patent/EP2470199B1/en active Active
- 2010-08-28 CN CN201610404696.3A patent/CN105999238A/zh active Pending
- 2010-08-28 US US12/870,790 patent/US8349319B2/en active Active
- 2010-08-28 CN CN201610403228.4A patent/CN106047835A/zh active Pending
- 2010-08-28 EP EP18199358.5A patent/EP3482767B1/en active Active
- 2010-08-28 EP EP21200695.1A patent/EP3998078B1/en active Active
- 2010-08-28 CN CN2010800439108A patent/CN102596232A/zh active Pending
- 2010-08-28 TR TR2019/11293T patent/TR201911293T4/tr unknown
- 2010-08-28 DK DK18199358.5T patent/DK3482767T3/da active
- 2010-08-28 HR HRP20191385 patent/HRP20191385T1/hr unknown
- 2010-08-28 KR KR1020257039475A patent/KR20250171458A/ko active Pending
- 2010-08-28 PT PT181993585T patent/PT3482767T/pt unknown
- 2010-08-28 SM SM20250432T patent/SMT202500432T1/it unknown
- 2010-08-28 PL PL10812683T patent/PL2470199T3/pl unknown
- 2010-08-28 SI SI201031915T patent/SI2470199T1/sl unknown
- 2010-08-28 PT PT10812683T patent/PT2470199T/pt unknown
- 2010-08-28 DK DK10812683.0T patent/DK2470199T3/da active
- 2010-08-28 LT LTEP10812683.0T patent/LT2470199T/lt unknown
- 2010-08-28 PL PL18199358T patent/PL3482767T3/pl unknown
- 2010-08-28 HU HUE18199358A patent/HUE057440T2/hu unknown
- 2010-08-28 HR HRP20211992TT patent/HRP20211992T1/hr unknown
- 2010-08-28 KR KR1020227023712A patent/KR102608551B1/ko active Active
- 2010-08-28 BR BR112012004377A patent/BR112012004377A2/pt not_active Application Discontinuation
- 2010-08-28 DK DK21200695.1T patent/DK3998078T3/da active
- 2010-08-28 PL PL21200695.1T patent/PL3998078T3/pl unknown
- 2010-08-28 KR KR1020207008342A patent/KR20200034828A/ko not_active Ceased
- 2010-08-28 HU HUE10812683A patent/HUE046598T2/hu unknown
- 2010-08-28 RU RU2012111823/15A patent/RU2569744C2/ru active
- 2010-08-28 PT PT212006951T patent/PT3998078T/pt unknown
- 2010-08-28 EP EP25204722.0A patent/EP4681775A3/en active Pending
- 2010-08-28 IL IL314807A patent/IL314807A/en unknown
- 2010-08-28 JP JP2012527054A patent/JP5955219B2/ja active Active
- 2010-08-28 ES ES10812683T patent/ES2738859T3/es active Active
- 2010-08-28 KR KR1020237040891A patent/KR102893390B1/ko active Active
- 2010-08-28 IL IL300625A patent/IL300625B2/en unknown
- 2010-08-28 SI SI201032163T patent/SI3998078T1/sl unknown
- 2010-08-28 ES ES18199358T patent/ES2902229T3/es active Active
- 2010-08-28 LT LTEP18199358.5T patent/LT3482767T/lt unknown
- 2010-08-28 CL CL2012000495A patent/CL2012000495A1/es unknown
- 2010-08-28 MX MX2012002449A patent/MX356873B/es active IP Right Grant
- 2010-08-28 SI SI201032100T patent/SI3482767T1/sl unknown
- 2010-08-28 FI FIEP21200695.1T patent/FI3998078T3/fi active
- 2010-08-28 MX MX2017009975A patent/MX392330B/es unknown
- 2010-08-28 KR KR1020217026374A patent/KR102608546B1/ko active Active
-
2012
- 2012-02-26 IL IL218324A patent/IL218324B/en active IP Right Grant
- 2012-02-27 ZA ZA2012/01435A patent/ZA201201435B/en unknown
- 2012-11-16 US US13/679,583 patent/US8658162B2/en active Active
- 2012-11-16 US US13/679,623 patent/US8709408B2/en active Active
-
2014
- 2014-01-16 US US14/156,894 patent/US9114139B2/en active Active
-
2015
- 2015-07-08 US US14/793,838 patent/US9655954B2/en active Active
-
2016
- 2016-02-26 ZA ZA2016/01362A patent/ZA201601362B/en unknown
- 2016-03-03 JP JP2016041242A patent/JP6251307B2/ja active Active
- 2016-08-17 AU AU2016216625A patent/AU2016216625B2/en active Active
-
2017
- 2017-04-12 US US15/485,604 patent/US10188705B2/en active Active
- 2017-11-24 JP JP2017226255A patent/JP2018076322A/ja active Pending
-
2018
- 2018-06-12 AU AU2018204156A patent/AU2018204156B2/en active Active
- 2018-12-04 US US16/209,336 patent/US20190151419A1/en not_active Abandoned
-
2019
- 2019-05-27 IL IL266915A patent/IL266915B2/en unknown
- 2019-07-29 CY CY20191100808T patent/CY1122128T1/el unknown
-
2020
- 2020-01-17 JP JP2020005901A patent/JP6952810B2/ja active Active
- 2020-05-26 US US16/883,407 patent/US20210077593A1/en not_active Abandoned
- 2020-10-13 AU AU2020256322A patent/AU2020256322B2/en active Active
-
2021
- 2021-09-28 JP JP2021157902A patent/JP7167281B2/ja active Active
-
2022
- 2022-02-18 US US17/675,474 patent/US20220305091A1/en active Pending
- 2022-10-26 JP JP2022171242A patent/JP7395693B2/ja active Active
- 2022-12-01 NO NO2022054C patent/NO2022054I1/no unknown
- 2022-12-06 LT LTPA2022526C patent/LTC3482767I2/lt unknown
- 2022-12-06 LU LU00288C patent/LUC00288I2/fr unknown
- 2022-12-08 HU HUS2200050C patent/HUS2200050I1/hu unknown
- 2022-12-15 FR FR22C1062C patent/FR22C1062I2/fr active Active
- 2022-12-20 FI FIC20220051C patent/FIC20220051I1/fi unknown
- 2022-12-20 NL NL301211C patent/NL301211I2/nl unknown
-
2023
- 2023-11-29 JP JP2023201609A patent/JP7605949B2/ja active Active
-
2024
- 2024-02-20 AU AU2024201085A patent/AU2024201085B2/en active Active
- 2024-12-12 JP JP2024217551A patent/JP2025038063A/ja active Pending
-
2025
- 2025-07-17 AU AU2025205539A patent/AU2025205539A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3998078T3 (fi) | Annoksensuurentamisentsyymikorvaushoito happaman sfingomyelinaasin puutoksen hoitamista varten | |
| KR20140025314A (ko) | 복합 조성물 | |
| BRPI0610873A2 (pt) | tratamento de doenças hepáticas em que o ferro desempenhe um papel na patogênese | |
| Jiang et al. | Current status of drug therapy for chronic hepatitis B | |
| JP2023524693A (ja) | ラクトフェリンの投与によるＳＡＲＳ－ＣｏＶ－２ウイルス侵入の阻害およびその使用 | |
| KR100709528B1 (ko) | 혈당콘트롤용 의약조성물 | |
| JP2024531799A5 (enExample) | ||
| CN102266562A (zh) | 一种用于治疗病毒性肝炎的药物组合物 | |
| EP3999069B1 (en) | Synergistic effect of eyp001 and pegylated ifn-alpha for the treatment of hbv infection | |
| JP2018135278A (ja) | 循環器疾患及び／又はミトコンドリア病の改善用医薬 | |
| CN101884643A (zh) | 含有吡格列酮和肝素或低分子肝素的药物组合物的新用途 | |
| JP2025527521A (ja) | 急性呼吸不全の治療 | |
| JP5117230B2 (ja) | ２型糖尿病治療用の併用医薬 | |
| CA3104916C (en) | Pharmaceutical composition for preventing diabetes and use thereof | |
| JP2770911B2 (ja) | 抗ウイルス医薬組成物 | |
| EP4149475A1 (en) | Compositions and methods for treating lung injuries associated with viral infections | |
| US20190381034A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases | |
| Leav et al. | Safety and pharmacokinetics of a novel human monoclonal antibody directed against the E2 glycoprotein of hepatitis C virus (MBL-HCV1) in healthy volunteers | |
| US20140275138A1 (en) | Method and products for treating diabetes | |
| HK40066536B (en) | Synergistic effect of eyp001 and pegylated ifn-alpha for the treatment of hbv infection | |
| HK40066536A (en) | Synergistic effect of eyp001 and pegylated ifn-alpha for the treatment of hbv infection | |
| CN113827597A (zh) | 化合物在制备治疗特发性肺纤维化的药物中的应用 | |
| RU2498797C2 (ru) | Комбинированное средство для лечения гриппа и орви | |
| CN115227712A (zh) | NaHS在制备治疗骨质疏松药物中的应用 | |
| EP2959888A1 (en) | A novel pharmaceutical composition of sofosbuvir and ribavirin |